new protease inhibitor, Aptivus (tipranavir)
August 2005
You'll see the new protease inhibitor, Aptivus (tipranavir).
It's the first NON-peptidic protease inhibitor (PI).
PIs have trouble adapting their shape when HIV protease enzymes mutate. Aptivus is more "flexible"...hopefully making it harder for resistance to develop.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote